About CryoCord
Most Trusted Stem Cell Company in Malaysia
Established in 2002, CryoCord is one of the largest and most comprehensive private stem cell companies in Southeast Asia, specialising in umbilical cord stem cells, immune cell banking, and cutting-edge research.
As a fully licensed stem cell bank under the Private Healthcare Facilities and Services (PHFS) Act 1998 by the Ministry of Health (MOH), CryoCord houses 10 Grade B (ISO Class 5) cleanrooms and a Biosafety Level 2 (BSL-2) GMP facility.
Our state-of-the-art laboratory is accredited by AABB and certified to cGMP in accordance with PIC/S standards set by the NPRA, a division of MOH Malaysia.
CryoCord Group holds multiple patents in cell-based technologies and has received several approvals from the MOH for clinical trials involving mesenchymal stem cells and CAR T-cells.
Vision
To be Asia’s leader in human cell and gene therapeutics research and development.
Mission Statement
To provide the best possible products and services to its customers by utilising advanced and sophisticated knowledge and skills whilst maintaining a strict code of ethics and professionalism in service delivery
Service Commitment
To provide the highest quality service to our customers and doctors. Every sample processed by CryoCord is deemed to be of utmost importance, hence we dedicate our effort to delivering top quality service without fail.
Core Values
Integrity • Excellence • Innovation
Milestones
2024 | Parenthood Magazine has recognised CryoCord as the Best Stem Cell Bank for the 7th consecutive year.
For the 13th consecutive year, CryoCord has received the Best Stem Cell Bank Award from Baby Talk Magazine. |
2023 | CryoCord has been awarded Best Stem Cell Bank for the 6th consecutive year by Parenthood Magazine.
CryoCord awarded Best Stem Cell Bank Award by Baby Talk Magazine, for the 12th consecutive year. |
2022 | Induced pluripotent stem cells (iPSCs) storage services made available in CryoCord. |
2021 | Collaboration with UM with approval from NPRA on the use of MSC to treat perianal fistula in patients with Crohn’s disease. |
2020 | CryoCord achieved accreditation by AABB (Association for the Advancement of Blood and Biotherapies).
CryoCord built the First Biosafety Level 2 (BSL-2) GMP facility in Malaysia. First CAR-T clinical trial approved in Malaysia, in collaboration between Plutonet (a member of the CryoCord Group) and HCTM (UKM). |
2019 | CryoCord honoured with the 2019 Malaysia Stem Cell Banking Company of the Year award by Frost & Sullivan at the Asia-Pacific Best Practices Awards.
CryoCord retains Best Stem Cell Bank Award by Baby Talk Magazine, for the 8th consecutive year. CryoCord has been awarded Best Stem Cell Bank for the 2nd consecutive year by Parenthood. Motherhood Choice 2019 Stem Cell Bank Award was awarded to CryoCord. CryoCord bagged Pa&Ma 2019 Preferred Stem Cell Bank Award. |
2018 | For the 7th time, CryoCord bagged the Best Stem Cell Bank Award by Baby Talk Magazine.
CryoCord has been awarded Best Stem Cell Bank by Parenthood. 28 Days Academy awarded CryoCord the Most Trusted Stem Cell Bank – Favourite Natal Care Service at the International Natal Care Awards 2018. |
2017 | CryoCord has been awarded Sin Chew Business Excellence Award by Sin Chew Daily.
CryoCord received the prestigious Sun Yat-Sen Enterprise Award from Kwong Wah Yit Poh Press Bhd. |
2016 | CryoCord has been awarded Best Stem Cell Bank award by BabyTalk Magazine for the fifth time.
CryoCord has garnered The BrandLaureate Best Brands in Sciences - Stem Cell Laboratory. |
2015 | CryoCord being awarded Best Stem Cell Bank for four consecutive years. |
2014 | For the third year in a row CryoCord being awarded Best Stem Cell Bank award by BabyTalk Magazine. CryoCord Group has extended its services by offering Contract GMP-Manufacturing and Research. Collaboration with UKM Ophthalmology Medical Centre (PPUKM) advances stem cells research in retina regeneration. |
2013 | CryoCord takes pride of place in its new Group Corporate Headquarters at Bio-X Centre, Cyberjaya. This architecturally stunning and purpose designed building is the new integrated seat of group management, administration, and laboratories.
|
2012 | 10th Anniversary is celebrated with a host of exciting and engaging nationwide activities. Acquisition of a BioNexus company, StemTech International Sdn Bhd, which was once a subsidiary of the Bursa listed TMC group. Baby Talk Magazine awarded CryoCord its Inaugural Best Stem Cell Bank, among all the stem cell banking companies in Malaysia. |
2011 | The establishment of Jakarta office at Mega Kuningan, Indonesia. |
2010 | Cytopeutics was absorbed to become part of CryoCord Group of Companies. |
2009 | A range of Mesenchymal Stem Cells (MSCs) storage services is launched. Awarded ISO 15189 certification by Laboratory Accreditation Scheme of Malaysia (SAMM). |
2008 | Awarded stem cell banking company’s license, under PHFS Act 1998 by the Ministry of Health, Malaysia. Sole distributorship of amnioPlas+ is awarded by USM. |
2007 | AXP® AutoXpress, the preferred cord blood stem cell processing platform designed and proven to maximize harvest quality, is made available to customers. A strategic partnership is forged with Cytopeutics, Malaysia's pioneering stem cell treatment and research group. |
2006 | First successful dual transplant using cord blood stem cells stored by CryoCord and bone marrow stem cells from sibling one of to another at Hospital Kuala Lumpur.
Staff count reaches 50. To enhance customer access, CryoCord is headquartered in Petaling Jaya. Laboratory remains in Cyberjaya. |
2004 | Branches in Brunei, Philippines and Thailand are established. MoU for collaboration on stem cell cryopreservation and research is signed with Intan Medical Centre, Pantai Group of Hospitals and Universiti Sains Malaysia. UKAS and ANAB confer CryoCord ISO 9001:2000 award. |
2003 | Operations commenced with a staff of 12. Awarded ISO 14644 Class 5 (Class 100) Cleanroom with HEPA filter, and certified to NASA and US Federal Standard 209E for processing samples. |
2002 | Dr. K. Y. Then and Emeritus Professor Dr. S. K. Cheong envisioned the concept of the establishment of a stem cell banking company in Malaysia. CryoCord was created on the talents, skills, experience and vision of a dedicated group of visionary medical and investment professionals. |